SNS812
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SNS812, covering 2024-09-19 to 2024-09-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Concentration of SNS812 in Mild to Moderate COVID-19 Patients [Phase 2]